RESUMEN

BACKGROUND: Gonadotropin-releasing hormone (GnRH) and its receptor (GnRHR) are both expressed by a number of malignant tumors, including those of the breast. In the latter, both behave as potent inhibitors of invasion. Nevertheless, the signaling pathways whereby the activated GnRH/GnRHR system exerts this effect have not been clearly established. In this study, we provide experimental evidence that describes components of the mechanism(s) whereby GnRH inhibits breast cancer cell invasion. METHODS: Actin polymerization and substrate adhesion was measured in the highly invasive cell line, MDA-MB-231 transiently expressing the wild-type or mutant DesK191 GnRHR by fluorometry, flow cytometric analysis, and confocal microscopy, in the absence or presence of GnRH agonist. The effect of RhoA-GTP on stress fiber formation and focal adhesion assembly was measured in MDA-MB-231 cells co-expressing the GnRHRs and the GAP domain of human p190Rho GAP-A or the dominant negative mutant GAP-Y1284D. Cell invasion was determined by the transwell migration assay. RESULTS: Agonist-stimulated activation of the wild-type GnRHR and the highly plasma membrane expressed mutant GnRHR-DesK191 transiently transfected to MDA-MB-231 cells, favored F-actin polymerization and substrate adhesion. Confocal imaging allowed detection of an association between F-actin levels and the increase in stress fibers promoted by exposure to GnRH. Pull-down assays showed that the effects observed on actin cytoskeleton resulted from GnRH-stimulated activation of RhoA GTPase. Activation of this small G protein favored the marked increase in both cell adhesion to Collagen-I and number of focal adhesion complexes leading to inhibition of the invasion capacity of MDA-MB-231 cells as disclosed by assays in Transwell Chambers. CONCLUSIONS: We here show that GnRH inhibits invasion of highly invasive breast cancer-derived MDA-MB-231 cells. This effect is mediated through an increase in substrate adhesion promoted by activation of RhoA GTPase and formation of stress fibers and focal adhesions. These observations offer new insights into the molecular mechanisms whereby activation of overexpressed GnRHRs affects cell invasion potential of this malignant cell line, and provide opportunities for designing mechanism-based adjuvant therapies for breast cancer.

Asunto(s)

Actinas/metabolismo , Movimiento Celular , Receptores LHRH/metabolismo , Proteína de Unión al GTP rhoA/metabolismo , Neoplasias de la Mama/genética , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Buserelina/metabolismo , Buserelina/farmacología , Línea Celular Tumoral , Activación Enzimática/efectos de los fármacos , Femenino , Citometría de Flujo , Fluorometría , Adhesiones Focales/efectos de los fármacos , Hormona Liberadora de Gonadotropina/farmacología , Humanos , Immunoblotting , Células MCF-7 , Microscopía Confocal , Mutación , Invasividad Neoplásica , Polimerizacion/efectos de los fármacos , Receptores LHRH/agonistas , Receptores LHRH/genética , Fibras de Estrés/metabolismo , Transfección , Proteína de Unión al GTP rhoA/genética

RESUMEN

AIM: The aims of the study were to understand the association between insulin-like factor 3 (INSL3) and functional ovarian hyperandrogenism (FOH) in PCOS and the regulatory role played by LH. SUBJECTS AND METHODS: Fifteen PCOS women were classified as FOH (FOH-PCOS, no.=8) and non-FOH (NFOH-PCOS, no.=7) according to the response of 17OH-progesterone to buserelin (a GnRH analogue) with respect to 15 controls. FOH-PCOS and NFOH-PCOS were compared for basal INSL3 levels. In addition, the effect of buserelin on INSL3 concentrations and the relationship between basal and buserelin-stimulated LH and 17OH-progesterone and INSL3 were evaluated. RESULTS: Basal INSL3 levels were higher in FOH-PCOS than NFOH-PCOS (p=0.001) and controls (p=0.001), whereas they did not differ between NFOHPCOS and controls. In addition, FOH-PCOS had a higher response of LH to buserelin with respect to NFOH-PCOS. Within all PCOS women the levels of INSL3 positively correlated with free testosterone (p=0.022) and negatively with SHBG (r= p=0.031). Moreover, positive correlations with the absolute increase of 17OH-progesterone (p<0.001) and with the LH area under the curve (p=0.001) after buserelin administration were found. In the multiple regression analysis INSL3 persisted significantly correlated only with 17OH-progesterone response to buserelin. Finally, INSL3 was not significantly modified after buserelin administration either in FOHPCOS or in NFOH-PCOS. CONCLUSIONS: These data suggest that INSL3 is related to FOH in PCOS women, but this association seems not to be mediated by LH, further reinforcing the concept that a pathophysiological heterogeneity for ovarian hyperandrogenism in PCOS exists.

Asunto(s)

Hiperandrogenismo/sangre , Hiperandrogenismo/fisiopatología , Insulina/sangre , Ovario/fisiopatología , Síndrome del Ovario Poliquístico/fisiopatología , 17-alfa-Hidroxiprogesterona/metabolismo , Adolescente , Adulto , Índice de Masa Corporal , Buserelina/metabolismo , Femenino , Fármacos para la Fertilidad Femenina/metabolismo , Hormona Liberadora de Gonadotropina/análogos & derivados , Hormona Liberadora de Gonadotropina/metabolismo , Humanos , Hormona Luteinizante/metabolismo , Persona de Mediana Edad , Ovario/anatomía & histología , Síndrome del Ovario Poliquístico/sangre , Proteínas , Adulto Joven

RESUMEN

Chaperone members of the protein disulfide isomerase family can catalyze the thiol-disulfide exchange reaction with pairs of cysteines. There are 14 protein disulfide isomerase family members, but the ability to catalyze a thiol disulfide exchange reaction has not been demonstrated for all of them. Human endoplasmic reticulum protein chaperone thio-oxidoreductase (ERp18) shows partial oxidative activity as a protein disulfide isomerase. The aim of the present study was to evaluate the participation of ERp18 in gonadotropin-releasing hormone receptor (GnRHR) expression at the plasma membrane. Cos-7 cells were cultured, plated, and transfected with 25 ng (unless indicated) wild-type human GnRHR (hGnRHR) or mutant GnRHR (Cys14Ala and Cys200Ala) and pcDNA3.1 without insert (empty vector) or ERp18 cDNA (75 ng/well), pre-loaded for 18 h with 1 microCi myo-[2-3H(N)]-inositol in 0.25 mL DMEM and treated for 2 h with buserelin. We observed a decrease in maximal inositol phosphate (IP) production in response to buserelin in the cells co-transfected with hGnRHR, and a decrease from 20 to 75 ng of ERp18 compared with cells co-transfected with hGnRHR and empty vector. The decrease in maximal IP was proportional to the amount of ERp18 DNA over the range examined. Mutants (Cys14Ala and Cys200Ala) that could not form the Cys14-Cys200 bridge essential for plasma membrane routing of the hGnRHR did not modify maximal IP production when they were co-transfected with ERp18. These results suggest that ERp18 has a reduction role on disulfide bonds in wild-type hGnRHR folding.

Asunto(s)

Membrana Celular/metabolismo , Proteína Disulfuro Reductasa (Glutatión)/metabolismo , Receptores LHRH/metabolismo , Animales , Buserelina/metabolismo , Buserelina/farmacología , Células COS , Membrana Celular/química , Chlorocebus aethiops , Humanos , Fosfatos de Inositol/metabolismo , Mutación , Proteína Disulfuro Reductasa (Glutatión)/genética

RESUMEN

Chaperone members of the protein disulfide isomerase family can catalyze the thiol-disulfide exchange reaction with pairs of cysteines. There are 14 protein disulfide isomerase family members, but the ability to catalyze a thiol disulfide exchange reaction has not been demonstrated for all of them. Human endoplasmic reticulum protein chaperone thio-oxidoreductase (ERp18) shows partial oxidative activity as a protein disulfide isomerase. The aim of the present study was to evaluate the participation of ERp18 in gonadotropin-releasing hormone receptor (GnRHR) expression at the plasma membrane. Cos-7 cells were cultured, plated, and transfected with 25 ng (unless indicated) wild-type human GnRHR (hGnRHR) or mutant GnRHR (Cys14Ala and Cys200Ala) and pcDNA3.1 without insert (empty vector) or ERp18 cDNA (75 ng/well), pre-loaded for 18 h with 1 µCi myo-[2-3H(N)]-inositol in 0.25 mL DMEM and treated for 2 h with buserelin. We observed a decrease in maximal inositol phosphate (IP) production in response to buserelin in the cells co-transfected with hGnRHR, and a decrease from 20 to 75 ng of ERp18 compared with cells co-transfected with hGnRHR and empty vector. The decrease in maximal IP was proportional to the amount of ERp18 DNA over the range examined. Mutants (Cys14Ala and Cys200Ala) that could not form the Cys14-Cys200 bridge essential for plasma membrane routing of the hGnRHR did not modify maximal IP production when they were co-transfected with ERp18. These results suggest that ERp18 has a reduction role on disulfide bonds in wild-type hGnRHR folding.

Asunto(s)

Animales , Humanos , Membrana Celular/metabolismo , Proteína Disulfuro Reductasa (Glutatión)/metabolismo , Receptores LHRH/metabolismo , Buserelina/metabolismo , Buserelina/farmacología , Chlorocebus aethiops , Células COS , Membrana Celular/química , Fosfatos de Inositol/metabolismo , Mutación , Proteína Disulfuro Reductasa (Glutatión)/genética

RESUMEN

The initiation and maintenance of reproductive function in mammals is critically dependent on the pulsatile secretion of gonadotropin-releasing hormone (GnRH). This peptide drives the pulsatile release of FSH and LH from the pituitary pars distalis via signaling pathways that are activated by the type I GnRH receptor (GnRH-R). Recently, a microarray analysis study reported that a number of genes, including mPer1, are induced by GnRH in immortalized gonadotrope cells. In view of these data, we have begun to analyze in detail the signaling pathways mediating the action of GnRH on mPer1 expression in these cells. Using quantitative real-time polymprose cho read (PCR), we could confirm that exposure of immortalized gonadotropes (LbetaT2 cells) to the GnRH analog, buserelin, markedly induces mPer1 (but not mPer2) expression. Consistent with GnRH receptor signaling via the protein kinase (PK)-C pathway, exposure of the cells to phorbol 12,13-dibutyrate rapidly elevates both mPer1 and LHbeta subunit mRNA levels, while pharmacological inhibition of PKC prevents the mPer1 and LHbeta response to buserelin. As GnRH is known to regulate gonadotropin synthesis via activation of p42/44 mitogen-activated protein kinase (MAPK) signaling pathways, we then examined the involvement of this pathway in regulating mPer1 expression in gonadotropes. Our data reveal that GnRH-induced mPer1 expression is blocked following acute exposure to a MAPK kinase inhibitor. Although the involvement of this signaling mechanism in the regulation of mPer1 is known in neurons, e.g., in the suprachiasmatic nuclei, the induction of mPer1 in gonadotropes represents a novel mechanism of GnRH signaling, whose functional significance is still under investigation.

Asunto(s)

Hormona Liberadora de Gonadotropina/metabolismo , Sistema de Señalización de MAP Quinasas , Proteínas Nucleares/biosíntesis , Proteína Quinasa C/metabolismo , Animales , Buserelina/metabolismo , Proteínas de Ciclo Celular , Línea Celular , Ratones , Neuronas/metabolismo , Proteínas Circadianas Period , Hipófisis/metabolismo , Reacción en Cadena de la Polimerasa , ARN Mensajero/metabolismo , Transducción de Señal

RESUMEN

GnRH agonists or antagonists are currently utilized as therapeutic agents in a number of diseases. A side-effect of prolonged treatment with GnRH analogues is hypoestrogenism. In this study, we tested the in vitro potency of different GnRH analogues originally found to be partial agonists (i.e. analogues with decreased efficacy for activating or stimulating their cognate receptor) as well as novel analogues, to identify compounds that might potentially be useful for partial blockade of gonadotrophin release. Cultured COS-7 cells transiently expressing the rat or human GnRH receptor (GnRHR) were exposed to increasing concentrations (10(-8) to 10(-5) M) of GnRH analogues (c(4-10)[Asp4,DNal6,Dpr10]-GnRH; c(4-10) [Dpr4,DNal6,Asp10]-GnRH; c(4-10)[Cys(4,10),DNal6]-GnRH; c[Eaca1,DNal6]-GnRH; c[Gly1,DNal6]-GnRH; c[betaAla1,DTrp6]-GnRH; c[Dava1,DNal6]-GnRH; c[Gaba1, DNal6]-GnRH), and the ability of these analogues to provoke or antagonize GnRH-stimulated inositol phosphate production was assessed. With both human and rat GnRHRs, c[Eaca1,DNal6]-GnRH, c[Gly1,DNal6]-GnRH, c[betaAla1,DTrp6]-GnRH and c[Dava1,DNal6]-GnRH exhibited partial agonist activity (35-87% of the maximal efficacy shown by 10(-6) M GnRH), whereas c[Gaba1,DNal6]-GnRH behaved as a partial agonist with the human GnRHR and as full agonist with the rat GnRHR. c(4-10)[Asp4, DNal6,Dpr10]-GnRH and c(4-10)[Dpr4,DNal6,Asp10]-GnRH exhibited full antagonist activity with both GnRHRs, and c(4-10) [Cys(4,10),DNal6]-GnRH was a weak, partial agonist with the human GnRHR and a full antagonist with the rat GnRHR. With the exception of c[Gaba1,DNal6]-GnRH stimulation of the human GnRHR, and c[Dava1,DNal6]-GnRH and c[Gaba1, DNal6]-GnRH stimulation of the rat GnRHR, all partial agonists also exhibited antagonist activity in the presence of the exogenous full agonist. The results demonstrate that structurally similar analogues display variable potencies and efficacies in vitro for a specific GnRHR as well as for the human versus the rat GnRHR. Their ultimate in vivo usefulness to treat clinical conditions in which complete suppression of gonadotroph activity is not required remains to be investigated.

Asunto(s)

Hormona Liberadora de Gonadotropina/agonistas , Hormona Liberadora de Gonadotropina/análisis , Animales , Unión Competitiva , Buserelina/metabolismo , Células COS , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Hormona Liberadora de Gonadotropina/metabolismo , Antagonistas de Hormonas/análisis , Humanos , Fosfatos de Inositol/biosíntesis , Unión Proteica , Ratas , Receptores LHRH/metabolismo , Transfección

RESUMEN

Loss of function by 11 of 13 naturally occurring mutations in the human GnRH receptor (hGnRHR) was thought to result from impaired ligand binding or effector coupling, but actually results from receptor misrouting. Homo- or heterodimerization of mutant receptors with wild-type (WT) receptors occurs for other G protein-coupled receptors and may result in dominant-negative or -positive effects on the WT receptor. We tested the hypothesis that WT hGnRHR function was affected by misfolded hGnRHR mutants. hGnRHR mutants were found to inhibit the function of WT GnRHR (measured by activation of effector and ligand binding). Inhibition varied depending on the particular hGnRHR mutant coexpressed and the ratio of hGnRHR mutant to WT hGnRHR cDNA cotransfected. The hGnRHR mutants did not interfere with the function of genetically modified hGnRHRs bearing either a deletion of primate-specific Lys(191) or the carboxyl-terminal tail of the catfish GnRHR; these show intrinsically enhanced expression. Moreover, a peptidomimetic antagonist of GnRH enhanced the expression of WT hGnRHR, but not of genetically modified hGnRHR species. The dominant-negative effect of the naturally occurring receptor mutants occurred only for the WT hGnRHR, which has intrinsic low maturation efficiency. The data suggest that this dominant negative effect accompanies the diminished plasma membrane expression as a recent evolutionary event.

Asunto(s)

Membrana Celular/metabolismo , Evolución Molecular , Receptores LHRH/genética , Receptores LHRH/metabolismo , Secuencia de Aminoácidos , Animales , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Buserelina/metabolismo , Buserelina/farmacología , Células COS , Fármacos para la Fertilidad Femenina/metabolismo , Fármacos para la Fertilidad Femenina/farmacología , Expresión Génica , Humanos , Indoles/farmacología , Fosfatos de Inositol/biosíntesis , Radioisótopos de Yodo , Datos de Secuencia Molecular , Mutagénesis , Unión Proteica/efectos de los fármacos , Estructura Terciaria de Proteína , Piridinas/farmacología , Receptores LHRH/química , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo

RESUMEN

The content, binding affinity, and bioactivity of chicken II GnRH (GnRH II) and a stable analogue of GnRH II (GnRH II analogue) in the baboon ovary were studied. Although mammalian GnRH is rapidly degraded by baboon ovarian extracts, we designed a GnRH II analogue that is stable to ovarian enzymatic degradation. This analogue binds to the ovarian membranes with high affinity (41 +/- 3 nM), having 20-fold the affinity of a potent mammalian GnRH analogue. The bioactivity of GnRH II and this GnRH II analogue on the regulation of ovarian progesterone release was compared with that for a potent mammalian GnRH analogue using a baboon granulosa cell culture system. Both GnRH II and GnRH II analogue produced significant inhibition of progesterone release from the granulosa cells (P < 0.03 and P < 0.005, respectively), with a greater reduction observed using the GnRH II analogue. After 24 h in culture, this GnRH II analogue produced a 59% +/- 5% inhibition of progesterone with a concentration as low as 1 nM. Maximal inhibition of 75% +/- 1% was attained with 10 nM GnRH II analogue. The endogenous GnRH II content in the baboon ovary was 5-14 pmoles/g protein. The release of endogenous GnRH II from granulosa cells was observed throughout the 48 h in culture. These studies demonstrated the presence of high enzymatic activity for the degradation of mammalian GnRH in the ovary, whereas this GnRH II analogue was stable. High-affinity binding sites for this GnRH II analogue were also found. GnRH II and this GnRH II analogue can regulate progesterone production from baboon granulosa cells, suggesting that GnRH II is a potent regulator of ovarian function.

Asunto(s)

Hormona Liberadora de Gonadotropina/fisiología , Ovario/fisiología , Animales , Sitios de Unión , Unión Competitiva , Buserelina/metabolismo , Buserelina/farmacología , Células Cultivadas , Pollos , Relación Dosis-Respuesta a Droga , Femenino , Fármacos para la Fertilidad Femenina/metabolismo , Fármacos para la Fertilidad Femenina/farmacología , Hormona Liberadora de Gonadotropina/administración & dosificación , Hormona Liberadora de Gonadotropina/análogos & derivados , Hormona Liberadora de Gonadotropina/metabolismo , Células de la Granulosa/efectos de los fármacos , Células de la Granulosa/metabolismo , Cinética , Hormona Luteinizante/metabolismo , Masculino , Ovario/química , Ovario/citología , Ovario/metabolismo , Papio , Hipófisis/citología , Hipófisis/metabolismo , Progesterona/antagonistas & inhibidores , Progesterona/metabolismo , Extractos de Tejidos/metabolismo

RESUMEN

A series of 2-arylindoles containing novel heteroaromatic substituents on the tryptamine tether, based on compound 1, was prepared and evaluated for their ability to act as gonadotropin releasing hormone (GnRH) antagonists. Successful modifications of 1 included chain length variation (reduction) and replacement of the pyridine with heteroaromatic groups. These alterations culminated in the discovery of compound 27kk which had excellent in vitro potency and oral efficacy in rodents.

Asunto(s)

Fármacos para la Fertilidad Femenina/antagonistas & inhibidores , Hormona Liberadora de Gonadotropina/antagonistas & inhibidores , Indoles/farmacología , Quinolinas/farmacología , Triptaminas/química , Administración Oral , Animales , Sitios de Unión , Buserelina/metabolismo , Humanos , Indoles/administración & dosificación , Indoles/química , Fosfatos de Inositol/metabolismo , Hormona Luteinizante/metabolismo , Masculino , Quinolinas/química , Ratas , Relación Estructura-Actividad

RESUMEN

OBJECTIVE: The presence of GnRH receptors in the human placenta has been recognized for a number of years. However, mammalian GnRH, which is expressed in placental tissues, has limited affinity for the chorionic receptor. On the basis of immunological and bioactivity data, we have previously proposed that the chorionic GnRH may differ from mammalian GnRH. METHODS: We have studied the affinity of another isoform of GnRH (ie, salmon GnRH and stable analogues of this GnRH isoform), and compared their receptor affinity to that of mammalian GnRH and its analogues. RESULTS: Using our receptor assay method with the labeled mammalian GnRH analogue Buserelin, salmon GnRH had a twofold greater affinity for the placental GnRH receptor than did mammalian GnRH and for the stable salmon GnRH analogue the affinity was increased tenfold. Using a homologous receptor assay method with a stable salmon GnRH analogue as label, the affinity for this salmon GnRH analogue had a K(d) of 101 nmol/L. CONCLUSION: The presence of these higher affinity receptors for non-mammalian GnRH in the human placenta has led us to propose that the chorionic tissues may express more than one isoform of GnRH and that non-mammalian GnRH, such as salmon GnRH, may be potent regulators of placental functions.

Asunto(s)

Hormona Liberadora de Gonadotropina/metabolismo , Placenta/química , Receptores LHRH/metabolismo , Buserelina/metabolismo , Femenino , Hormona Liberadora de Gonadotropina/análogos & derivados , Humanos , Radioisótopos de Yodo , Embarazo

RESUMEN

Nonmammalian vertebrates express at least two forms of GnRH and distinct forms of GnRH receptor (GnRH-R) have coevolved with their ligands. Mammalian and nonmammalian GnRH-R have key structural differences (notably the lack of C-terminal tails in mammalian GnRH-R) and comparative studies are beginning to reveal their functional relevance. However, cellular context and receptor density influence G protein-coupled receptor function and may be important variables in such work using heterologous expression systems. Here we report a comparative study using alphaT4 cells (gonadotrope progenitors that lack endogenous GnRH-R) transfected with a mammalian (human) or nonmammalian (Xenopus laevis type I) GnRH-R. Because conventional transfection strategies proved inefficient, recombinant adenovirus expressing these receptors were constructed, enabling controlled and efficient GnRH-R expression. When expressed in alphaT4 cells at physiological density, these GnRH-Rs retain the pharmacology of their endogenous counterparts (as judged by ligand specificity in radioligand binding and inositol phosphate accumulation assays) but do not activate adenylyl cyclase and are not constitutively active. Moreover, the Xenopus GnRH-R rapidly desensitizes and internalizes in these cells, whereas the human GnRH-R does not, and the internalization rates are not dependent upon receptor number. These data extend studies in COS, HEK, and GH3 cells showing that other GnRH-R with C-terminal tails desensitize and internalize rapidly, whereas tail-less mammalian GnRH-R do not. Retention of these distinctions at physiological receptor density in gonadotrope lineage cells, supports the argument that the evolution of nondesensitizing mammalian GnRH-Rs is functionally relevant and related to the development of mammalian reproductive strategies.

Asunto(s)

Adenoviridae/genética , Expresión Génica , Hormona Liberadora de Gonadotropina/análogos & derivados , Hipófisis/metabolismo , Receptores LHRH/genética , Receptores LHRH/metabolismo , Xenopus laevis/metabolismo , Adenilil Ciclasas/metabolismo , Animales , Unión Competitiva , Buserelina/metabolismo , Línea Celular , Activación Enzimática , Hormona Liberadora de Gonadotropina/metabolismo , Humanos , Inositol 1,4,5-Trifosfato/metabolismo , Fosfatos de Inositol/metabolismo , Radioisótopos de Yodo , Cinética , Proteínas Recombinantes/metabolismo , Células Madre/metabolismo , Transfección

RESUMEN

The mammalian gonadotropin-releasing hormone (GnRH) receptor (GnRH-R) has been a therapeutic target for human and animal medicine. This receptor is a unique G-protein-coupled receptor that lacks the intracellular C-terminal domain commonly associated with this family. Development of highthrough put screens for agents active in humans has been hampered by low expression levels of the hGnRH-R in cellular models. Two sites have attracted the interest of laboratories studying regulation of expression. The chimeric addition of the C-terminal tail from catfish GnRH-R (cfGnRH-R) to the rat GnRH-R significantly augmented receptor expression in GH3 cells. In addition, rodent GnRH-R contains 327 amino acids, but cow, sheep, and human GnRH-R (hGnRH-R) contain 328 residues, the "additional" residue being a Lys 191. Deletion of Lys 191 (del 191) from the hGnRH-R resulted in increased receptor expression levels and decreased internalization rates in both COS-7 and HEK 293 cells. In this study, the combined effect of the addition of the C-tail from cfGnRH-R and deletion of the Lys 191 from the hGnRH-R was compared to expression of the wild-type (WT) or either alteration alone in a transient expression system using primate cells. The altered receptor (hGnRH-R[del 191]-C-tail) showed significantly increased receptor expression at the cell surface compared with the WT or either modification alone. The inositol phosphate response to stimulation was also significantly elevated in response to GnRH agonist. After treatment with a GnRH agonist, the altered receptors showed a slower internalization rate. The homologous steady-state regulation of the WT and the altered receptors was similar, although the response of the altered receptors was significantly decreased. These results suggest that the conformational change in the receptor as a result of the deletion of Lys 191 and the addition of the C-terminus tail substantially increased the steady-state receptor expression and decreased internalization and homologous regulation. Because the effects on expression are greater than additive, it appears that these alterations exert their effects by differing means. These techniques for expression of the hGnRH-R in transfected mammalian cells provide the basis for a therapeutic screen for GnRH analogs, agonists, and antagonists of the hGnRH.

Asunto(s)

Expresión Génica , Receptores LHRH/química , Receptores LHRH/genética , Relación Estructura-Actividad , Secuencia de Aminoácidos , Animales , Buserelina/metabolismo , Células COS , Bagres , Línea Celular , Eliminación de Gen , Humanos , Fosfatos de Inositol/metabolismo , Radioisótopos de Yodo , Cinética , Lisina , Ratones , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Conformación Proteica , Ratas , Receptores LHRH/metabolismo , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/metabolismo , Transfección

RESUMEN

Human term placental cytosol fractions decreased the specific binding of gonadotrophin-releasing hormone (GnRH) isoform tracers to placental membranes (and to rat pituitary GnRH receptors and anti-GnRH antibodies) in a dose-dependent manner, and in parallel to GnRH standard curves. However, cytosol fractions had little or no effect on the binding of two GnRH superagonist tracers. The specificity of placental binding sites for a range of GnRH-like and unrelated peptides was shown to be similar with GnRH isoforms or GnRH agonists as binding ligands, suggesting that isoforms and agonists did not bind to different forms of the GnRH-receptor. Inclusion of a cocktail of protease inhibitors during the preparation of placental cytosol significantly reduced immuno- and receptor-binding activity. Moreover, incubation of radiolabelled chicken GnRH II with placental cytosol led to marked inactivation of tracer, as assessed by radioreceptor and radioimmunoassays for GnRH, high resolution liquid chromatography, thin layer chromatography and adsorption to dextran-coated charcoal and other matrices. There was a good negative correlation between tracer degradation and apparent GnRH immuno- and receptor-binding activities. These results emphasize the important effects which proteases in un-denatured tissue extracts can have on radioreceptor and radioimmunoassays due to inactivation of peptide tracers, and suggest that previous measurements of receptor- and immuno-active GnRH-like factors may have been over-estimated due to peptidase action during the GnRH assay.

Asunto(s)

Hormona Liberadora de Gonadotropina/metabolismo , Placenta/metabolismo , Radioinmunoensayo/métodos , Receptores LHRH/metabolismo , Adsorción , Animales , Anticuerpos/metabolismo , Buserelina/metabolismo , Carbón Orgánico/química , Cromatografía Liquida/métodos , Cromatografía en Capa Delgada/métodos , Citosol/metabolismo , Femenino , Hormona Liberadora de Gonadotropina/agonistas , Hormona Liberadora de Gonadotropina/antagonistas & inhibidores , Hormona Liberadora de Gonadotropina/inmunología , Humanos , Radioisótopos de Yodo/metabolismo , Radioisótopos de Yodo/farmacocinética , Microsomas/metabolismo , Hipófisis/citología , Hipófisis/metabolismo , Embarazo , Isoformas de Proteínas , Ratas , Ratas Sprague-Dawley

RESUMEN

The phospholipase C (PLC)-activating gonadotrophin-releasing hormone (GnRH) receptor is thought not to rapidly desensitise in alphaT3-1 cells. This extremely unusual characteristic raises the concern that it might be a feature of the cell type, rather than the receptor per se. Here we have used video imaging to establish whether the effects of endogenous PLC-activating G-protein coupled receptors (GPCRs) on Ca2+ ion concentration [Ca2+]i desensitise in these cells. Oxytocin, endothelin-1, methacholine, and UTP all caused [Ca2+]i increases which underwent rapid homologous desensitisation in that they were transient and responses to repeat stimuli were attenuated whereas subsequent responses to GnRH were not. To test whether receptor reserve obscures functional desensitisation of GnRH receptors, a photoaffinity antagonist (Pant-1), was used to effect a partial and irreversible receptor blockade. UV crosslinking in medium with 1000 nM Pant-1 reduced GnRH receptor number to 20 +/- 5% and reduced maximal buserelin-stimulated [3H]IP(X) accumulation to 57 +/- 5%, demonstrating removal of receptor reserve. In control alphaT3-1 cells the initial rate of GnRH-stimulated [3H]IP(X) accumulation was maintained for at least 5 min and GnRH caused a sustained increase in Ins(1,4,5)P3 mass (confirming the resistance of GnRH receptors to desensitisation) and Pant-1 pre-treatment reduced the magnitude of these responses without altering their temporal profiles. In alphaT3-1 cells stably transfected with recombinant human muscarinic receptors (alphaT3-1/M3), responses to methacholine were characteristic of desensitising GPCRs (transient Ins(1,4,5)P3 and curvilinear [3H]IP(X) responses) and were unaltered by Pant-1. To test the relevance of phospholipid pool size, alphaT3-1/M3 cells were pre-treated with GnRH or methacholine in medium with LiCl (to deplete PtdIns(4,5)P2 pools). These pre-treatments reduced subsequent responses to methacholine and GnRH comparably, indicating access to a shared PtdIns(4,5)P2 pool. Partial depletion of this pool (GnRH pre-treatment in medium with LiCl) reduced the magnitude of the [3H]IP(X) and Ins(1,4,5)P3 responses to methacholine and GnRH, without altering their temporal profiles. Thus the GnRH receptor does not undergo rapid homologous desensitisation in alphaT3-1 cells in spite of the fact that they can desensitise other endogenous (and recombinant) PLC-activating GPCRs, and the lack of desensitisation cannot be attributed to the existence of GnRH receptor reserve or access to an atypically large or rapidly re-cycled PtdIns(4,5)P2 pool. This unique functional characteristic (mammalian GnRH receptors are the only PLC-activating GPCRs known not to rapidly desensitise) almost certainly therefore reflects the atypical structure of these receptors (mammalian GnRH receptors are the only PLC-activating GPCRs known to lack C-terminal tails).

Asunto(s)

Fosfatidilinositol 4,5-Difosfato/metabolismo , Receptores LHRH/fisiología , Animales , Buserelina/metabolismo , Buserelina/farmacología , Calcio/metabolismo , Línea Celular , Regulación hacia Abajo/efectos de los fármacos , Endotelina-1/farmacología , Proteínas de Unión al GTP/metabolismo , Hormona Liberadora de Gonadotropina/farmacología , Humanos , Fosfatos de Inositol/metabolismo , Cinética , Cloruro de Litio/farmacología , Cloruro de Metacolina/farmacología , Ratones , Oxitocina/farmacología , Etiquetas de Fotoafinidad/metabolismo , Etiquetas de Fotoafinidad/farmacología , Receptor Muscarínico M3 , Receptores de Superficie Celular/metabolismo , Receptores de Superficie Celular/fisiología , Receptores LHRH/agonistas , Receptores LHRH/antagonistas & inhibidores , Receptores LHRH/metabolismo , Receptores Muscarínicos/genética , Receptores Muscarínicos/metabolismo , Fosfolipasas de Tipo C/metabolismo , Uridina Trifosfato/farmacología

RESUMEN

Pituitary cell lines (GGH3) expressing the GnRH receptor (GnRHR) were used to investigate the effect of GnRHR concentration on the ability of a GnRH agonist to activate second messenger systems. Four different strategies were utilized to generate cells expressing functionally different concentrations of receptors: (1) transient transfection with different concentrations of wild type GnRHR into GH3 cells, (2) utilization of two cell lines derived from a common stably transfected line expressing high (4,209 +/- 535 receptors/cell) or low (1,031 +/- 36 receptors/cell) concentrations of GnRHR, (3) co-incubation of GGH3-1' cells with a GnRH agonist (Buserelin) and a GnRH antagonist to compete for binding sites, and (4) photo-affinity binding to GnRHR with a GnRH antagonist to change effective receptor concentration. A range of receptor concentrations (1,000-8,000 receptors/cell) were generated by these techniques. Inositol phosphate (IP) and cAMP accumulation were quantified to assess the effect of receptor concentration on receptor-effector coupling. Under all four paradigms, the efficacy and potency of Buserelin stimulated IP production was dependent on receptor concentration. In contrast, Buserelin stimulated cAMP release was relatively unchanged at varying concentrations of GnRHR. This suggests that the cellular concentration of GnRHR affects the induction of cell signaling pathways. These results demonstrate that a single ligand-receptor-complex can differentially activate second messenger systems and present a mechanism by which multiple physiological endpoints can be differentially regulated by a single hormone/receptor interaction.

Asunto(s)

Hipófisis/metabolismo , Receptores LHRH/metabolismo , Sistemas de Mensajero Secundario , Animales , Antineoplásicos Hormonales/metabolismo , Antineoplásicos Hormonales/farmacología , Buserelina/metabolismo , Buserelina/farmacología , AMP Cíclico/metabolismo , Relación Dosis-Respuesta a Droga , Hormona Liberadora de Gonadotropina/análogos & derivados , Hormona Liberadora de Gonadotropina/metabolismo , Hormona Liberadora de Gonadotropina/farmacología , Antagonistas de Hormonas/metabolismo , Antagonistas de Hormonas/farmacología , Fosfatos de Inositol/metabolismo , Etiquetas de Fotoafinidad , Hipófisis/citología , Hipófisis/efectos de los fármacos , Ratas , Receptores LHRH/agonistas , Receptores LHRH/antagonistas & inhibidores , Receptores LHRH/genética , Sistemas de Mensajero Secundario/efectos de los fármacos , Transfección , Células Tumorales Cultivadas , Rayos Ultravioleta

RESUMEN

The present experiments were designed in order to elucidate the participation of the developing hypophysis in determining the changing sensitivity of gonadotrophins to gonadotropin-releasing hormone (GnRH) during ontogeny in the rat. To that end, we chose two well defined developmental ages that differ markedly in sexual and ontogenic characteristics of hypophyseal sensitivity to GnRH, 15 and 30 d. In order to study sex differences and the role of early sexual organization of the hypothalamus, experiments were carried out in males, females, and neonatally androgenized females (TP females). We evaluated (1) the characteristics of pituitary GnRH receptors, and (2) associated changes in GnRH-induced mobilization of intracellular Ca2+ (a second messenger involved in gonadotropins exocytosis). We measured binding characteristics of the GnRH analog D-Ser(TBu)6-des-Gly10-GnRH ethylamide in pituitary homogenates. We found that Kds did not vary among the different sex groups. Total number and concentration of receptors decreased in the female rat from 15-30 d of age, whereas in the male and TP female, receptors/pituitary increased, and the concentration/mg tissue did not change. Also, at 30 days of age, males presented higher content and concentration of receptors than females, and higher content than TP females. In order to evaluate if developmental and sexual differences in pituitary sensitivity to GnRH might be expressed through variations in the intracellular Ca2+ signal, we studied the mobilization of intracellular Ca2+ induced by GnRH (1 x 10(-8) to 1 x 10(-11) M) in a suspension of dispersed pituitary cells in the six groups. In cells from 15-d-old females, Ca2+ response was greater than in 30-d-old females at the doses of 10(-8) to 10(-10) M, indicating that in the infantile female rat activation of highly concentrated GnRH receptors is reflected in an increase in signal transduction mediated by Ca2+. In males and in female rats androgenized at birth, there was also a decrease in the magnitude of intracellular, Ca2+ mobilization induced by GnRH (10(-8) to 10(-10) M) from 15-30 d of age, even though the concentration of GnRH receptors did not change in the same period. In conclusion, the present results suggest that high sensitivity to GnRH, which has been described in the female infantile rat, may be related to elevated concentration of hypophyseal receptors coupled to an increase of intracellular calcium response to GnRH, both parameters decreasing as the rat matures. In males, the greater sensitivity that has been described for GnRH at 30 d in comparison to 15 d is paralleled by an increase in the total number of GnRH receptors per pituitary (and not in their concentration), but not in an increase in the magnitude of Ca2+ mobilization induced by GnRH. On the other hand, neonatal sexual organization of the hypothalamus is involved in the differential expression of GnRH receptors, but does not modulate mobilization of intracellular Ca2+ induced by the decapeptide.

Asunto(s)

Calcio/metabolismo , Adenohipófisis/crecimiento & desarrollo , Adenohipófisis/metabolismo , Receptores LHRH/fisiología , Caracteres Sexuales , Envejecimiento , Animales , Buserelina/metabolismo , Femenino , Hormona Liberadora de Gonadotropina/farmacología , Radioisótopos de Yodo , Masculino , Adenohipófisis/efectos de los fármacos , Ratas , Ratas Sprague-Dawley

RESUMEN

Decidualization of endometrial tissues, which is essential for implantation and the continuation of pregnancy, is induced by pituitary hormones that are regulated by gonadotropin releasing hormone (GnRH). Our objective was to determine the role of a direct action of GnRH on endometrial tissues by comparing the characteristics of receptors for GnRH in human endometrial and decidual tissues. Competitive binding studies were performed with the protease-resistant GnRH analogues, buserelin and [125I] buserelin. The effects of buserelin on phosphoinositol turnover were determined by the measurement of inositol 1,4,5-triphosphate(IP3). The values for the dissociation constant (Kd) and number of binding sites (Bmax) per unit protein versus buserelin for endometrial tissues did not differ from the values for decidual tissues. However, the Bmax per unit DNA was significantly higher in endometrial tissues. Also, buserelin induced a significant increase in IP3 in decidual tissue. These results indicate that GnRH may be a potential modulator of the function in human endometrium and decidua. The signal transduction mechanism for GnRH action appeared to involve the accelerated turnover of phosphoinositol.

Asunto(s)

Decidua/efectos de los fármacos , Endometrio/efectos de los fármacos , Hormona Liberadora de Gonadotropina/farmacología , Unión Competitiva , Buserelina/metabolismo , Decidua/metabolismo , Decidua/ultraestructura , Endometrio/metabolismo , Endometrio/ultraestructura , Femenino , Hormona Liberadora de Gonadotropina/metabolismo , Hormona Liberadora de Gonadotropina/fisiología , Humanos , Radioisótopos de Yodo , Cinética , Embarazo , Receptores LHRH/metabolismo , Receptores LHRH/fisiología , Transducción de Señal/fisiología

RESUMEN

PURPOSE: The present study addresses how maltosyl-beta-cyclodextrin (G2-beta-CyD) impacts upon the alpha-chymotrypsin-catalyzed hydrolysis of buserelin acetate, an agonist of luteinizing hormone-releasing hormone with emphasis upon the direct effect of G2-beta-CyD on the activity of the protease. METHODS: Kinetic and solubility studies were performed in isotonic phosphate buffer (pH 7.4) at 25 degrees C and 37 degrees C. The interaction of alpha-chymotrypsin with G2-beta-CyD in the buffer solution was examined by differential scanning calorimetry. RESULTS: G2-beta-CyD decelerated the alpha-chymotrypsin-catalyzed hydrolysis of buserelin acetate to give the 1-3 tripeptide and the 4-9 hexapeptide fragments. This deceleration can be explained solely by a non-productive encounter between a complex of the substrate with G2-beta-CyD and the protease at relatively low CyD concentrations, while the direct inhibitory effect of G2-beta-CyD on the proteolytic activity made a considerable contribution to the overall deceleration of the hydrolysis at higher CyD concentrations. Calorimetric studies indicate the presence of intermediate states in the thermal unfolding of alpha-chymotrypsin, simultaneously accompanied by the autolysis. By contrast, a two-state thermal unfolding of alpha-chymotrypsin was observed in the presence of G2-beta-CyD, suggesting reduced proteolytic activity upon binding to G2-beta-CyD. CONCLUSIONS: These results suggest that G2-beta-CyD at higher concentrations inhibits the proteolytic action of alpha-chymotrypsin through direct interaction with the protease, as well as through the formation of a non-productive complex with the substrate.

Asunto(s)

Buserelina/metabolismo , Quimotripsina/antagonistas & inhibidores , Ciclodextrinas/farmacología , Inhibidores Enzimáticos/metabolismo , Hormona Liberadora de Gonadotropina/agonistas , beta-Ciclodextrinas , Buserelina/química , Rastreo Diferencial de Calorimetría , Catálisis , Cromatografía Líquida de Alta Presión , Quimotripsina/química , Ciclodextrinas/química , Inhibidores Enzimáticos/química , Hidrólisis , Cinética , Desnaturalización Proteica

RESUMEN

Complex of copper with the gonadotropin-releasing hormone, GnRH, competed more efficiently for the GnRH receptor than native GVRH, while complexes of nickel with GnRH and zinc with GnRH had slightly lower affinity. Copper ion added to the incubation mixture inhibited the buserelin binding to the receptor.

Asunto(s)

Cobre/metabolismo , Hormona Liberadora de Gonadotropina/metabolismo , Níquel/metabolismo , Adenohipófisis/metabolismo , Receptores LHRH/metabolismo , Zinc/metabolismo , Animales , Unión Competitiva , Buserelina/metabolismo , Cinética , Ratas

RESUMEN

Inclusion complexation of buserelin acetate, and agonist of luteinizing hormone-releasing hormone, with dimethyl-beta-cyclodextrin (DM-beta-CyD) in aqueous solution was studied spectroscopically and its mode of interaction was assessed. Ultraviolet absorption and circular dichroism (CD) spectroscopies indicate that the aromatic side chains of buserelin acetate, L-tryptophan and L-tyrosine residues, are incorporated into the hydrophobic environment of the DM-beta-CyD activity. Furthermore, proton and carbon-13 nuclear magnetic resonance spectroscopies suggest that in addition to the two aromatic side chains, a tertiary butyl D-serine residue is inserted into the DM-beta-CyD cavity from the secondary hydroxyl side. On the other hand, the continuous variation plots for the buserelin acetate: DM-beta-CyD system showed a 1:1 stoichiometry of the complex. Therefore, the complexation should be initiated by the inclusion of one of the three binding sites on the buserelin molecule into DM-beta-CyD, which may in turn prevent the further access of the second cyclodextrin to the other binding sites, probably due to steric hindrance and/or conformational changes of the peptide. These structural features of the complex would account for the stabilizing effect of DM-beta-CyD on the enzymatic degradation of buserelin acetate.

Asunto(s)

Buserelina/metabolismo , Ciclodextrinas/metabolismo , Sustancias de Crecimiento/metabolismo , beta-Ciclodextrinas , Dicroismo Circular , Espectroscopía de Resonancia Magnética , Modelos Químicos , Conformación Proteica , Espectrofotometría Ultravioleta